Lensar (LNSR) Net Income towards Common Stockholders (2019 - 2026)
Lensar (LNSR) reported Net Income towards Common Stockholders of $35000.0 for Q1 2026, up 100.13% year-over-year from $17488.8 in Q1 2025, and up 102.4% on a QoQ basis from -$1.5 million in Q4 2025.
Lensar (LNSR) has 8 years of Net Income towards Common Stockholders data on file, last reported at $35000.0 in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 100.13% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (up 87.81% YoY) and the FY2025 annual result came in at -$34.3 million, down 9.16% from the prior year.
- Net Income towards Common Stockholders grew to $35000.0 in Q1 2026 per LNSR's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $1.4 million in Q3 2023 and bottomed at -$27.3 million in Q1 2025.
- The 5-year median for Net Income towards Common Stockholders is -$3.9 million (2023), against an average of -$5.9 million.
- The widest annual swing landed in 2023, when Net Income towards Common Stockholders surged 135.91%; it then plunged 1167.73% in 2025.
- Tracing LNSR's Net Income towards Common Stockholders over 5 years: stood at -$2.5 million in 2022, then tumbled by 57.67% to -$3.9 million in 2023, then tumbled by 376.36% to -$18.7 million in 2024, then surged by 92.2% to -$1.5 million in 2025, then jumped by 102.4% to $35000.0 in 2026.
- Per Business Quant, the three latest LNSR Net Income towards Common Stockholders figures stand at $35000.0 (Q1 2026), -$1.5 million (Q4 2025), and -$3.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | -1.46 Mn |
| Sep 30, 2025 | -3.71 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -27.35 Mn |
| Dec 31, 2024 | -18.70 Mn |
| Sep 30, 2024 | -1.50 Mn |
| Jun 30, 2024 | -9.04 Mn |
| Mar 31, 2024 | -2.16 Mn |
| Dec 31, 2023 | -3.93 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | -8.75 Mn |
| Mar 31, 2023 | -4.27 Mn |
| Dec 31, 2022 | -2.49 Mn |
| Sep 30, 2022 | -3.99 Mn |
| Jun 30, 2022 | -6.76 Mn |
| Mar 31, 2022 | -6.67 Mn |
| Dec 31, 2021 | -3.90 Mn |
| Sep 30, 2021 | -6.16 Mn |
| Jun 30, 2021 | -4.36 Mn |
| Mar 31, 2021 | -5.18 Mn |
| Dec 31, 2020 | -6.83 Mn |
| Sep 30, 2020 | -4.76 Mn |
| Jun 30, 2020 | -4.50 Mn |
| Mar 31, 2020 | -3.69 Mn |
| Dec 31, 2019 | -2.47 Mn |
| Sep 30, 2019 | -5.82 Mn |